Emma Stanton from the Ellison Institute of Technology (EIT) in the UK presented at London Calling 2025 on “EIT Pathogena and Oxford Nanopore Technologies revolutionising infectious disease.” Stanton started as a medical doctor and spoke about interdisciplinary teams driving impacts for patient care. The Ellison Institute of Technology was envisioned by a co-founder of Oracle. the EIT Oxford campus is being built and is near the Oxford Nanopore Technologies campus. There will be synthetic biology group and a program in food security. Stanton is a chief executive of the pathogen program. The team will use real-time sequencing to improve surveillance and prevent disease. The team is leveraging the global data platform provided by Oracle. The tools they have in EIT Pathogena include a couple of bioinformatics platforms that are cloud-based and provide predictive antibiotic profiles for Mycobacterium tuberculosis and SARS-CoV-2. The team is deploying MinION devices in numerous sites globally to “get genomics out of the lab and into real-world clinical settings.” What a neat collaboration! I wonder how open the platforms will be!
